Hepion Pharmaceuticals Inc
PublicHepion Pharmaceuticals Inc is now publicly traded
The data on this page reflects Hepion Pharmaceuticals Inc's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Follow-on Offering
Apr 22, 2026
Total Funding Raised
$700,000
Company Overview
Hepion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that focuses on the development of drug therapies for the treatment of chronic liver diseases.
Sector
Healthcare
AI Layer
Application
Keywords
NASH treatmentrencofilstatliver disease treatmentcyclophilin inhibitorHCC treatmentNASHAI drug discoveryclinical-stage biopharmanon-alcoholic steatohepatitisHCCsmall molecule drughepatocellular carcinomaanti-fibrotic therapybiotechdrug licensingliver cancer treatmentfatty liver disease
Hepion Pharmaceuticals Inc Comparables
Compare Hepion Pharmaceuticals Inc with similar companies based on industry and business-model similarity.
Hepion Pharmaceuticals Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Apr 22, 2026 |
Hepion Pharmaceuticals Inc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersUnited States
Employee Range4
Year Founded2013
Last FundingApr 22, 2026
See something wrong or outdated?